Business Wire

VIRTUOZZO

3.6.2021 12:32:08 CEST | Business Wire | Press release

Share
Mick Bradley Named New Vice President of Global Sales at Virtuozzo

Virtuozzo , a global leader in high-efficiency virtualization and hyperconverged software solutions, has welcomed Mick Bradley as its new Vice President of Global Sales. Mick joins Virtuozzo with over 25 years of sales leadership and management experience in the IT/Software industry, including a strong track record of building successful teams in early and growth-stage organizations while driving sales excellence and partner strategies. Mick will steer Virtuozzo’s global sales team executing the overall sales strategy, including expanding and improving its sales capabilities to support the growth of new customers and its core customer base – Virtuozzo’s network of 450+ service provider partners.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210603005288/en/

Mick’s appointment comes at a pivotal time for Virtuozzo as the Company accelerates growth in new and existing markets. Virtuozzo’s product portfolio is well suited to provide end-to-end cloud enablement for the fast-growing service provider market – both hosting service providers and the Company’s new vertical focus, managed and cloud service providers. Mick’s expertise and leadership will help drive the Company’s strategic vision and accelerate its growth, building upon over 21 years of innovation in the virtualization software business.

Previously Mick served as Senior Vice President & General Manager for EMEA at Arcserve, where he developed and implemented a strategy to move Arcserve from SMB into mid-markets and SME, resulting in significant revenue growth, channel expansion, and a successful transition to cloud service. Prior to this, he held several senior positions, including VP & General Manager for EMEA at Kaminario Inc., EMEA Managing Director at Violin Memory, Senior Director of EMEA Storage Consulting at Hewlett Packard, Chief Operating Officer at CopperEye, and Senior Vice President of Global Services at COPAN Systems.

“We’re thrilled to welcome Mick at such a critical time in Virtuozzo’s evolution. His extensive leadership and sales expertise will help establish Virtuozzo as the global leader in hybrid cloud enablement for the service provider market. Under Mick’s leadership, our sales team is well positioned to continue accelerating our business with a strong global team, solid solution portfolio, and a customer base of 450 service providers worldwide. With his expertise in growing both global and startup sales organizations in the software industry, Mick will bring our business to the next level. We couldn't be more excited," said Alex Fine, CEO, Virtuozzo.

“I’m joining Virtuozzo during an exciting time for both the Company and our partners and look forward to leveraging my experience to help both achieve massive growth. Virtuozzo’s ability to quickly offer cutting-edge cloud services is a game-changer for service providers seeking to differentiate and disrupt today. I am thrilled to be joining Virtuozzo and look forward to great things to come,” remarked Mick Bradley, VP of Global Sales, Virtuozzo.

About Virtuozzo

Virtuozzo is a leading, global provider of hybrid virtualization, storage, and cloud enablement software solutions. The Company's software-defined, hyperconverged self-service platform and resource management capabilities enable hosting and service providers to provide end-customers with public and private cloud services. Virtuozzo is an industry pioneer who developed the first commercially available container technology 21 years ago. The Company provides software solutions and services to over 450 service providers, ISVs, and enterprises worldwide to enable over 500 thousand virtual environments, running mission-critical cloud workloads. A significant force in the open-source community, Virtuozzo sponsors and/or is a contributor to numerous open-source projects including KVM, Docker, OpenStack, OpenVZ, CRIU, and the Linux kernel. Learn more https://go.virtuozzo.com/l/148051/2021-06-02/5kjhgs .

Link:

ClickThru

Social Media:

https://www.facebook.com/VirtuozzoInc/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release

Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo

NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release

NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding

European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release

European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili

Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye